TOPICAL AVASTIN EFFECTIVE FOR CORNEAL NEOVASCULARIZATION

Arch Ophthalmol -- Abstract: Topical Bevacizumab in the Treatment of Corneal Neovascularization: Results of a Prospective, Open-Label, Noncomparative Study, April 2009, Dastjerdi et al. 127 (4): 381:


"Short-term topical bevacizumab therapy reduces the severity of corneal NV without local or systemic adverse effects."

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH